Gestala raises record $62 million for non-invasive ultrasound BCIs
Founded in 2025, Gestala is committed to developing ultrasound-based non-invasive BCIs, an alternative to conventional implanted electrical systems.
Founded in 2025, Gestala is committed to developing ultrasound-based non-invasive BCIs, an alternative to conventional implanted electrical systems.
The three products currently target different aspects of enterprise productivity.
The achievement comes as Chinese technology companies continue to face security-related restrictions and procurement scrutiny in several overseas markets.
Investment activity recovered strongly in 2025, with both deal value and transaction volumes reaching record highs after a slump in 2024.
Interest in optical interconnect technologies has accelerated alongside the rapid expansion of AI infrastructure.
The IPO marks Westwell’s latest attempt to reach the public markets after several false starts.